You are here

Article Text

Article menu

other Versions

Download PDFPDF
Review
Still no place for depot triamcinolone in hay fever?
  1. Yuet Wan
  1. London and South East Regional Medicines Information, Guy's and St Thomas' NHS Foundation Trust, London, UK
  1. Correspondence to Ms Yuet Wan, Guy's and St Thomas' NHS Foundation Trust, London, UK; yuet.wan{at}gstt.nhs.uk

Abstract

Topics for DTB review articles are selected by DTB’s editorial board to provide concise overviews of medicines and other treatments to help patients get the best care. Articles include a summary of key points and a brief overview for patients.

  • Allergic conditions
  • Drug safety

https://doi.org/10.1136/dtb.2019.000060

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Editor's note This article is based on a UKMi Medicines Q&A document ‘Is there a place in therapy for Kenalog (triamcinolone acetonide) intramuscular injection for seasonal allergic rhinitis (hay fever)?’

    • Correction notice This article has been corrected since it was published online. The previous version was an uncorrected paper and it has now been updated.

    • Competing interests None declared. Refer to the online supplementary files to view the ICMJE form(s).

    • Provenance and peer review Commissioned; externally peer reviewed.